NewLink Genetics Corp (NLNK)

10.99
NASDAQ : Health Care
Prev Close 10.81
Day Low/High 10.38 / 11.74
52 Wk Low/High 5.90 / 25.17
Avg Volume 1.99M
Exchange NASDAQ
Shares Outstanding 29.42M
Market Cap 318.04M
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers

The company is scheduled Friday afternoon to present comprehensive data from its Phase 3 study of rucaparib at the European Society for Medical Oncology Congress in Madrid.

Indoximod Plus Pembrolizumab Data From Phase 2 Trial In Advanced Melanoma (Graphic: Business Wire)

Indoximod Plus Pembrolizumab Data From Phase 2 Trial In Advanced Melanoma (Graphic: Business Wire)

NewLink Genetics Corporation (NASDAQ: NLNK) today announced updated data from the ongoing Phase 2 NLG2103 study of indoximod, NewLink Genetics' IDO pathway inhibitor, in combination with the PD-1 pathway inhibitor,...

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

And a management shakeup helps push down NuVasive.

NewLink Genetics Reports Second Quarter 2017 Financial Results And Updates Indoximod Program

NewLink Genetics Reports Second Quarter 2017 Financial Results And Updates Indoximod Program

Management to Host Conference Call Today at 8:30 a.m. ET

Interesting NLNK Put And Call Options For August 18th

Investors in NewLink Genetics Corp saw new options begin trading this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NLNK options chain for the new August 18th contracts and identified one put and one call contract of particular interest.

Biotech Movers: NewLink, Inovio, Juno

Biotech Movers: NewLink, Inovio, Juno

NewLink Genetics, Inovio Pharmaceuticals and Juno Therapeutics were among the biotech stock movers in premarket trading on Thursday.

NewLink Genetics To Regain Rights To GDC-0919

Management to Host Conference Call Thursday, June 8 at 8:30 am ET

Notable Wednesday Option Activity: NLNK, WTW, GEF

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in NewLink Genetics Corp , where a total of 2,935 contracts have traded so far, representing approximately 293,500 underlying shares. That amounts to about 47.5% of NLNK's average daily trading volume over the past month of 617,940 shares.

Commit To Buy NewLink Genetics Corp At $10, Earn 23.3% Annualized Using Options

Investors considering a purchase of NewLink Genetics Corp shares, but tentative about paying the going market price of $11.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $10 strike, which has a bid at the time of this writing of $1.45.

Biotech Movers: Loxo, NewLink, BioCryst

Biotech Movers: Loxo, NewLink, BioCryst

Loxo Oncology, NewLink Genetics and BioCryst Pharmaceuticals were among the biotech movers in premarket trading on Monday.

Incyte Shares Vault After 'IDO' Cancer Immunotherapy Combo Data Revealed

Incyte Shares Vault After 'IDO' Cancer Immunotherapy Combo Data Revealed

The new Incyte data revealed ahead of the ASCO meeting in June involve combination therapies with Merck and Bristol-Myers Squibb in multiple types of cancer.

Relative Strength Alert For NewLink Genetics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Newman Ferrara LLP Announces Corporate Governance Investigation Of NewLink Genetics Corporation - NLNK

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of NewLink Genetics Corporation ("NewLink" or the "Company") (NASDAQ:NLNK) into potential breaches of fiduciary duty...

NewLink Genetics Reports First Quarter 2017 Financial Results And Updates Clinical Trial Guidance

Management to Host Conference Call Today at 8:30 a.m. ET

Six Stocks Spiking Up With Huge Volume

Six Stocks Spiking Up With Huge Volume

Here's a technical look at how to play six stocks trending higher with strong volume.

TheStreet Quant Rating: D (Sell)